陳榮基TAIWAN

我的相片
Taiwan
姓名陳榮基現任恩主公醫院教授/顧問醫師 神經學兼任教授. 曾任(台灣大學/台北醫學大學)教授, 醫院評鑑暨醫療品質策進會顧問,台灣失智症協會名譽理事長,台灣腦中風醫學會名譽理事長,中華慧炬佛學會理事長,佛教蓮花基金會董事長,健康世界雜誌社社長.慧炬雜誌社發行人, 佛教僧伽醫護基金會董事,華梵大學董事. [曾任]恩主公醫院創院院長,台大醫院副院長,台大醫學院/附設醫院神經科教授及主任,台大醫學院生理學科教授.台灣神經學學會理事長,台灣安寧照顧協會理事長,消費者文教基金會理事/監事長,佛教醫事人員聯合會理事長,台灣神經學學會雜誌(Acta Neurologica Taiwanica)創刊總編輯. [學歷] 台大醫學院醫科畢業,黎巴嫩貝魯特美國大學(American Univ of Beirut)進修(WHO復健醫學訓練班),美國威斯康辛大學(Univ of Wisconsin-Madison)神經科進修, 日本福岡九州大學腦神經研究所進修. [獎項]醫師醫療奉獻獎(台灣醫師公會全國聯合會,2007/11/12),越南衛生部人民健康奉獻獎(2010/10/11)Received a Medal for People's Heath from the Ministry of Health of Vietnam on Oct. 11, 2010. 周大觀文教基金會全球熱愛生命獎章.(2011/04/16).

2014年8月22日 星期五

Dying Peace


Dying Peace  By Johnson Wu, DO

Austin Family Medicine Resident, Tuesday, August 19, 2014 

 A recent CBC News story showcased a research study conducted by Harvard Medical School and Cornell Medical College that examined what happens to patients who received palliative chemotherapy. Palliative chemotherapy is the use of medications for cancer patients to ease symptoms and prolong survival but not to cure their disease. The study showed that 68 percent of patients who received palliative chemotherapy died in the place they wanted; within this group, 47 percent died at home. By contrast, 80 percent of patients who did not receive palliative chemotherapy died in the place they wished, and among these patients, 66 percent died at home. Unfortunately, patients who received palliative chemotherapy were less likely to realize their illness was terminal and less likely to discuss end-of-life care with their families and physicians.

Full text:    http://www.meandmydoctor.com/   

References cited in Dr. Wu’s above article (published in NEJM)


 
 
 

沒有留言 :